HEAD NECK CANCER

Clinical trials for HEAD NECK CANCER explained in plain language.

Never miss a new study

Get alerted when new HEAD NECK CANCER trials appear

Sign up with your email to follow new studies for HEAD NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 20 Not yet recruiting 6 Not yet finished but already full! 3 Terminated 1

Can a new drug combo revive Immunotherapy's power against resistant tumors?

Disease control Terminated

This trial is testing whether an experimental drug called NC410, when combined with the immunotherapy drug pembrolizumab, can safely and effectively treat people with advanced solid tumors that have not responded to standard immunotherapy or that are unlikely to respond. The stud…

Matched conditions: HEAD NECK CANCER

Phase: PHASE1, PHASE2 • Sponsor: NextCure, Inc. • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC

HEAD NECK CANCER

Get alerted when new HEAD NECK CANCER trials appear

Can a new drug combo revive Immunotherapy's power against resistant tumors?